These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 29698802

  • 1. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 2. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A, Galli M, Piga I, Denti V, Stella M, Chinello C, Fusco N, Leni D, Manzoni M, Roversi G, Garancini M, Pincelli AI, Cimino V, Capitoli G, Magni F, Pagni F.
    J Proteomics; 2019 Jan 16; 191():114-123. PubMed ID: 29581064
    [Abstract] [Full Text] [Related]

  • 3. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.
    Urol Oncol; 2016 Jan 16; 34(1):5.e11-25. PubMed ID: 26420021
    [Abstract] [Full Text] [Related]

  • 4. Tumor size, stage and grade alterations of urinary peptidome in RCC.
    Chinello C, Cazzaniga M, De Sio G, Smith AJ, Grasso A, Rocco B, Signorini S, Grasso M, Bosari S, Zoppis I, Mauri G, Magni F.
    J Transl Med; 2015 Oct 20; 13():332. PubMed ID: 26482227
    [Abstract] [Full Text] [Related]

  • 5. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
    Zhao Z, Lu J, Qu H, Wang Z, Liu Q, Yang X, Liu S, Ge J, Xu Y, Li N, Yuan Y.
    Hum Pathol; 2018 Oct 20; 80():87-93. PubMed ID: 29935195
    [Abstract] [Full Text] [Related]

  • 6. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
    Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Srigley JR, Coughlin G, Dunglinson N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Yaxley J, Samaratunga H.
    Histopathology; 2017 Dec 20; 71(6):918-925. PubMed ID: 28718911
    [Abstract] [Full Text] [Related]

  • 7. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
    Gianazza E, Chinello C, Mainini V, Cazzaniga M, Squeo V, Albo G, Signorini S, Di Pierro SS, Ferrero S, Nicolardi S, van der Burgt YE, Deelder AM, Magni F.
    J Proteomics; 2012 Dec 05; 76 Spec No.():125-40. PubMed ID: 22868251
    [Abstract] [Full Text] [Related]

  • 8. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
    Djidja MC, Francese S, Loadman PM, Sutton CW, Scriven P, Claude E, Snel MF, Franck J, Salzet M, Clench MR.
    Proteomics; 2009 May 05; 9(10):2750-63. PubMed ID: 19405023
    [Abstract] [Full Text] [Related]

  • 9. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
    Chinello C, Stella M, Piga I, Smith AJ, Bovo G, Varallo M, Ivanova M, Denti V, Grasso M, Grasso A, Del Puppo M, Zaravinos A, Magni F.
    J Proteomics; 2019 Jan 16; 191():29-37. PubMed ID: 29689304
    [Abstract] [Full Text] [Related]

  • 10. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
    Yang J, Yang J, Gao Y, Zhao L, Liu L, Qin Y, Wang X, Song T, Huang C.
    PLoS One; 2014 Jan 16; 9(11):e111364. PubMed ID: 25368985
    [Abstract] [Full Text] [Related]

  • 11. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.
    Cocco E, Leo M, Canzonetta C, Di Vito S, Mai A, Rotili D, Di Napoli A, Vecchione A, De Nunzio C, Filetici P, Stoppacciaro A.
    Clin Epigenetics; 2018 Jan 16; 10():44. PubMed ID: 29632619
    [Abstract] [Full Text] [Related]

  • 12. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J, Liu P, Tian M, Li Y, Chen W, Li X.
    Int J Oncol; 2013 Jun 16; 42(6):2078-86. PubMed ID: 23588948
    [Abstract] [Full Text] [Related]

  • 13. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X, Desgrandchamps F, Mongiat-Artus P, Feugeas JP.
    Am J Surg Pathol; 2018 Apr 16; 42(4):423-441. PubMed ID: 29356723
    [Abstract] [Full Text] [Related]

  • 14. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
    Delahunt B, McKenney JK, Lohse CM, Leibovich BC, Thompson RH, Boorjian SA, Cheville JC.
    Am J Surg Pathol; 2013 Mar 16; 37(3):311-22. PubMed ID: 23348209
    [Abstract] [Full Text] [Related]

  • 15. Prediction of ISUP grading of clear cell renal cell carcinoma using support vector machine model based on CT images.
    Sun X, Liu L, Xu K, Li W, Huo Z, Liu H, Shen T, Pan F, Jiang Y, Zhang M.
    Medicine (Baltimore); 2019 Apr 16; 98(14):e15022. PubMed ID: 30946334
    [Abstract] [Full Text] [Related]

  • 16. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.
    Vieira de Ribeiro AJ, Sandim V, Ornellas AA, Reis RS, Domont G, Alves G.
    Int Braz J Urol; 2013 Apr 16; 39(1):83-94. PubMed ID: 23510786
    [Abstract] [Full Text] [Related]

  • 17. Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
    Lkhagvadorj S, Kim JH, Oh SS, Lee MR, Jung JH, Chung HC, Cha SK, Eom M.
    J Korean Med Sci; 2016 Jun 16; 31(6):879-85. PubMed ID: 27247496
    [Abstract] [Full Text] [Related]

  • 18. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.
    BJU Int; 2011 Jul 16; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [Abstract] [Full Text] [Related]

  • 19. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
    Yang J, Li X, Tian MJ, Wang LN, Cheng TT, Chen W.
    Zhonghua Zhong Liu Za Zhi; 2012 Aug 16; 34(8):571-6. PubMed ID: 23158988
    [Abstract] [Full Text] [Related]

  • 20. Mutational heterogeneity between different regional tumour grades of clear cell renal cell carcinoma.
    Ferronika P, Kats-Ugurlu G, Haryana SM, Utoro T, Rinonce HT, Danarto R, de Lange K, Terpstra MM, Sijmons RH, Westers H, Kok K.
    Exp Mol Pathol; 2020 Aug 16; 115():104431. PubMed ID: 32259515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.